Evaluation of novel targeted small-molecule therapeutics in desmoplastic small round cell tumor (DSRCT) cells
Anne Hahn, Julia Hentschel, Shifa Saleem, Sabine Becker, Thomas Liehr, Andreas Schober, Oliver H. Krämer, Jürgen Sonnemann, Christian Marx · 2026
Read Evaluation of novel targeted small-molecule therapeutics in desmoplastic small round cell tumor (DSRCT) cells by Anne Hahn, Julia Hentschel, Shifa Saleem, Sabine Becker, Thomas Liehr, Andreas Schober, Oliver H. Krämer, Jürgen Sonnemann, Christian Marx (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634027.txt.
Description
Anne Hahn and colleagues screened targeted drugs against a rare, brutal childhood sarcoma in the lab. Desmoplastic small round cell tumor spreads fast and resists standard care. The team used a cell line carrying the tumor's signature gene fusion and tested drugs that avoid directly damaging DNA.
Two epigenetic drugs and one that frees the guardian protein p53 killed the cells through the cell's own death program. A transcription blocker was potent too, while a common targeted drug did nothing. Blocking the death machinery rescued the cells, confirming the route. The screen names candidates worth testing beyond the dish.
Catalog record
| CREATOR | Anne Hahn, Julia Hentschel, Shifa Saleem, Sabine Becker, Thomas Liehr, Andreas Schober, Oliver H. Krämer, Jürgen Sonnemann, Christian Marx |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |